🇺🇸 Clopidogrel and Aspirin in United States

20 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 20

Most-reported reactions

1. Angioedema — 2 reports (10%)
2. C-Reactive Protein Increased — 2 reports (10%)
3. Chronic Gastritis — 2 reports (10%)
4. Dysphagia — 2 reports (10%)
5. Eosinophil Count Increased — 2 reports (10%)
6. Glossitis — 2 reports (10%)
7. Hypophagia — 2 reports (10%)
8. Mouth Ulceration — 2 reports (10%)
9. Pain — 2 reports (10%)
10. Red Blood Cell Sedimentation Rate Increased — 2 reports (10%)

Source database →

Frequently asked questions

Is Clopidogrel and Aspirin approved in United States?

Clopidogrel and Aspirin does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Clopidogrel and Aspirin in United States?

Beijing Tiantan Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.